MEDICURE
About Us - Products In Development - Clinical Trials - Investor Relations - Latest News - Contact Us Contact Us Latest News Investor Relations Clinical Trials Products in Development About Us Medicure

News Releases 2004

Medicure Announces Development of MC-4262 Combination Product
November 18, 2004

Medicure Drug Discovery Program Further Strengthened With Issuance Of New Patent
November 5, 2004

Medicure to Present at Rodman & Renshaw Techvest Global Healthcare Conference in New York
October 25, 2004

Medicure Announces First Quarter Results
October 14, 2004

Medicure Medicure To Webcast Cardiovascular Symposium in New York
October 12, 2004

Medicure Discovers Breakthrough Drug for Prevention of Blood Clots
October 6, 2004

Medicure Announces Positive Phase I Results With New Intravenous Formulation of MC-1
September 20, 2004

Leading Experts to Present at Cardiovascular Symposium Hosted
by Medicure in New York

September 13, 2004

Medicure Announces Fiscal 2004 Results
August 25, 2004

Medicure Initiates Patient Enrolment in Phase II
Combination Therapy Trial With MC-4232

August 11, 2004

Medicure to Present at American Stock Exchange Online
Healthcare and Biotech Investor Conference

June 21, 2004

Medicure Accepted to Present at the Major BIO 2004 Conference and Convention in San Francisco
May 28, 2004

Medicure Receives First European Patent
May 18, 2004

Medicure to Present at Two Major Biotech Conferences
April 30, 2004

Medicure Reports Third Quarter Financial Results
April 22, 2004

Preliminary Results From Hypertension Trial Support Expansion of MC-4232 Program
April 7, 2004

Medicure To Host Conference Call On MC-4232 Program<
April 6, 2004

Medicure Initiates Patient Enrolment in Phase II/III MEND-CABG Clinical Trial
April 5, 2004

Medicure Receives Patent Relating to Combination Products
for Treatment of Hypertension

March 10, 2004

Medicure Receives Ninth Patent Approval for Treatment of Cardiovascular Diseases
February 27, 2004

Medicure Commences Trading on American Stock Exchange
February 17, 2004

Medicure Receives Approval for American Stock Exchange Listing
January 28, 2004

Gerald McDole, Former CEO of AstraZeneca, Appointed to Medicure Board of Directors
January 21, 2004

Medicure to Present at Two Upcoming International Biotech Conferences
January 15, 2004

Medicure Announces Second Quarter Financial Results
January 12, 2004

Back to Latest News
News Archives

2004 Archives

2003 Archives

Legal - Privacy
For more information please email us: info@medicure.com